Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The European market for vascular access devices will see slight growth over the forecast period, driven in large part by the rising adoption of PICCs in all European countries, as well as the rising adoption of new technologies such as power-injectable devices, and devices with antimicrobial coatings. However, market revenues will be hindered to some extent by declining ASPs resulting from pricing pressures and increasing competition.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for vascular access devices in Europe across a 10-year period.
Companies have developed innovative products designed to reduce the likeliness of catheter-related BSIs and clot formation.
How will the various vascular access device markets be affected by the introduction of novel technologies?
What innovative products have companies introduced in Europe to cater to this unmet need? How will these products be adopted over the forecast period?
Which regions will see stronger adoption of these innovative devices and which regions will experience restricted growth?
How will clinical trials examining the incidence of DVT among vascular access patients impact the market?
The PICC segment will see rapid growth in Europe.
How does the adoption of PICCs vary between countries and what factors are responsible for these differences?
How will the rapid adoption of PICCs affect other vascular access device segments?
Power-injectable devices will account for a large and growing proportion of the market.
Which segments will see the highest adoption of power-injectable devices?
What advantage does power-injectability provide and what role it will play in the growth of vascular access device market?
Already a Client? Log in to access this report.
Bishwjit Ghoshal is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.